“The Utility of a Model-Based Cost-Effectiveness Analysis of Degarelix Versus Leuprolide in the Therapy of Hormone-Dependent Advanced Prostate Cancer”. Farmeconomia. Health Economics and Therapeutic Pathways 14, no. 3 (September 11, 2013): 131–146. Accessed February 15, 2026. https://journals.seedstm.com/index.php/FE/article/view/700.